Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022

Rhea-AI Summary

Singular Genomics Systems, Inc. (Nasdaq: OMIC) will release its third quarter 2022 financial results on November 7, 2022. A conference call with management is scheduled for 1:30 p.m. Pacific Time/4:30 p.m. Eastern Time to discuss these results. The company specializes in next-generation sequencing (NGS) and multiomics technologies, offering the G4 Sequencing Platform, a benchtop sequencer designed for speed and accuracy, along with the development of the PX system for in-situ analysis of RNA and proteins at the single-cell level.

Positive

• Strong focus on advancing next-generation sequencing and multiomics technologies.
• G4 Sequencing Platform is commercially available, enhancing research capabilities.

Negative

• None.

SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the third quarter 2022 after the market close on Monday, November 7, 2022. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine.

Investor Contact
Matt Clawson
949-370-8500
ir@singulargenomics.com

Media Contact
Dan Budwick, 1AB
973-271-6085
dan@1abmedia.com

FAQ

When will Singular Genomics report its Q3 2022 financial results?

Singular Genomics will report its Q3 2022 financial results on November 7, 2022.

What time is the conference call for Singular Genomics Q3 2022 results?

The conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

What technologies does Singular Genomics focus on?

Singular Genomics focuses on next-generation sequencing and multiomics technologies.

What is the G4 Sequencing Platform?

The G4 Sequencing Platform is a benchtop genomic sequencer designed to produce fast and accurate sequencing results.

How can investors access the results conference call?

Investors can access the live and archived webcast of the conference call at the investor website of Singular Genomics.